Figure 4
Figure 4. DFS and OS according to MRD level after allogeneic SCT. After SCT both MRD >1% and >10% translated into a poor outcome with a significantly higher risk to develop relapse or die. (A-B) DFS after SCT analyzed for increasing NPM1mut/ABL1 >1% (A) and NPM1mut/ABL1 >10% (B). (C-D) OS after SCT for the corresponding subgroups.

DFS and OS according to MRD level after allogeneic SCT. After SCT both MRD >1% and >10% translated into a poor outcome with a significantly higher risk to develop relapse or die. (A-B) DFS after SCT analyzed for increasing NPM1mut/ABL1 >1% (A) and NPM1mut/ABL1 >10% (B). (C-D) OS after SCT for the corresponding subgroups.

Close Modal

or Create an Account

Close Modal
Close Modal